High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma.
about
Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in CancerQuercetin as an Emerging Anti-Melanoma Agent: A Four-Focus Area Therapeutic Development StrategyUnderstanding the biology of melanoma and therapeutic implicationsEpigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanomaDNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features.Genotyping of cutaneous melanoma.DNA-methylation profiling distinguishes malignant melanomas from benign nevi.Melanoma genotypes and phenotypes get personal.Clinically relevant genes and regulatory pathways associated with NRASQ61 mutations in melanoma through an integrative genomics approach.Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanomaCtBP1 is expressed in melanoma and represses the transcription of p16INK4a and Brca1.Age-related epigenetic drift in the pathogenesis of MDS and AML.NRAS mutant melanoma: biological behavior and future strategies for therapeutic management.Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities.Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma.Induction of Therapeutic Senescence in Vemurafenib-Resistant Melanoma by Extended Inhibition of CDK4/6The genomic landscape of childhood and adolescent melanoma.High-frequency p16(INK) (4A) promoter methylation is associated with histone methyltransferase SETDB1 expression in sporadic cutaneous melanoma.CDK4 inhibitors an emerging strategy for the treatment of melanoma
P2860
Q26739706-93A22A70-47AE-4243-BC7D-6190B3BBD9DFQ28076840-E7F880D7-15FF-4DAE-8D2D-C7D5CC9DFC38Q33978378-7288209F-634B-4086-ADA8-190392F696EAQ34031613-4F061C72-5234-479F-A97A-2D959B710889Q34416046-A4196148-73F6-47FA-B837-CE53AEE358B0Q34667738-7929F89C-F36C-4814-9EC0-EF621184C151Q34775571-509C3FDC-D44D-4A67-82EC-DA507AB5F58AQ34788817-EB588DDB-59CF-4A08-AD3B-ECEBF35B8C9EQ35273776-43B51013-9A31-4C96-8AF8-EA607315DE25Q35706499-72C15E0F-C7A9-4FDC-8F86-84F914EA7DB6Q37013798-08985A62-BE9E-40AF-9C27-014914BA81E4Q37683456-A6512DB1-D5C9-4A8E-9D54-BD4CCC1A900FQ37689575-5285F623-BE88-4C94-AB6A-16EB15FC8B63Q37737945-9098E060-BD58-40A5-8E1A-0699B258EF3EQ38953667-1778CBC9-6EFD-4CC9-B7F0-15AA2C9B2519Q42775668-1DD9F7F7-354F-4594-96B9-D443A475E87BQ43163168-78BB6132-92F9-4686-BD1F-6FA52336D8D7Q43728956-88AB75F3-3341-4EEF-B292-EFAFBBAD642EQ57571832-77F2E47A-231A-4C91-9278-65A1B87A5A58
P2860
High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
High frequency of p16
@nl
High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma.
@en
type
label
High frequency of p16
@nl
High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma.
@en
prefLabel
High frequency of p16
@nl
High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma.
@en
P2093
P356
P1476
High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma.
@en
P2093
Anders Jonsson
Eva Grafström
Johan Hansson
Rainer Tuominen
Suzanne Egyhazi
P2888
P304
P356
10.1038/JID.2010.216
P407
P577
2010-08-12T00:00:00Z
P5875
P6179
1012750944